Soligenix Inc (SNGX)

0.9646 -0.02  -1.97% NASDAQ Jul 23, 20:00 USD
View Full Chart
Price Chart
View All SNGX News

News

View All Events

Events

Date Type Description
11/12/2021 Earnings Results Q3 2021 Earnings Results
05/17/2021 Earnings Results Q1 2021 Earnings Results
03/30/2021 Earnings Results Q4 2020 Earnings Results
11/12/2020 Earnings Results Q3 2020 Earnings Results
09/16/2020 09:00 EST AGM 2019 Annual General Meeting
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
  • URL: https://www.soligenix.com
  • Investor Relations URL: N/A
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: May. 17, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.